Anordrin
General
Type : Pro-Drug || Drug || Propionate
Chemical_Nomenclature : [(2R,3aS,3bS,5aS,6R,8aS,8bR,10aS)-2,6-diethynyl-3a,5a-dimethyl-2-propanoyloxy-1,3,3b,4,5,7,8,8a,8b,9,10,10a-dodecahydroindeno[5,4-e]inden-6-yl] propanoate
Canonical SMILES : CCC(=O)OC1(CCC2C1(CCC3C2CCC4C3(CC(C4)(C#C)OC(=O)CC)C)C)C#C
InChI : InChI=1S\/C28H38O4\/c1-7-23(29)31-27(9-3)17-19-11-12-20-21(25(19,5)18-27)13-15-26(6)22(20)14-16-28(26,10-4)32-24(30)8-2\/h3-4,19-22H,7-8,11-18H2,1-2,5-6H3\/t19-,20+,21-,22-,25-,26-,27+,28-\/m0\/s1
InChIKey : NOECSYBNZHIVHW-LKADTRSGSA-N
Other name(s) : alpha-Anordrin, AF-53, 6R25F2A061, SCHEMBL18906509, 2alpha, 17alpha-diethynyl-A-nor-5alpha-androstane-2beta, 17beta-diol dipropionate
Target
Families : Carb_B_Chordata
References (1)
| Title : Predominant contributions of carboxylesterase 1 and 2 in hydrolysis of anordrin in humans - Jiang_2017_Xenobiotica__1 |
| Author(s) : Jiang J , Chen X , Zhong D |
| Ref : Xenobiotica , :1 , 2017 |
| PubMedID: 28532270 |
| Gene_locus related to this paper: human-CES1 |